HRSA Sanctions Drugmaker, Reports No Covered Entity ‘Adverse Findings’ in Early FY 26 Audits
Federal regulators recently sanctioned a Puerto Rican pharmaceutical manufacturer, but reported no adverse findings for another drugmaker and 20 covered [...]
